"Cholecystokinin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A peptide, of about 33 amino acids, secreted by the upper INTESTINAL MUCOSA and also found in the central nervous system. It causes gallbladder contraction, release of pancreatic exocrine (or digestive) enzymes, and affects other gastrointestinal functions. Cholecystokinin may be the mediator of satiety.
| Descriptor ID |
D002766
|
| MeSH Number(s) |
D06.472.317.152 D12.644.120
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cholecystokinin".
Below are MeSH descriptors whose meaning is more specific than "Cholecystokinin".
This graph shows the total number of publications written about "Cholecystokinin" by people in this website by year, and whether "Cholecystokinin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 2 | 2 |
| 1995 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 1998 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cholecystokinin" by people in Profiles.
-
Badour CL, Hirsch RL, Zhang J, Mandel H, Hamner M, Wang Z. Exploring the association between a cholecystokinin promoter polymorphism (rs1799923) and posttraumatic stress disorder in combat veterans. J Anxiety Disord. 2015 Dec; 36:78-83.
-
Irshad A, Ackerman SJ, Spicer K, Baker NL, Baker N, Campbell A, Anis M, Shazly M. Ultrasound evaluation of gallbladder dyskinesia: comparison of scintigraphy and dynamic 3D and 4D ultrasound techniques. AJR Am J Roentgenol. 2011 Nov; 197(5):1103-10.
-
Prpic V, Fitz JG, Wang Y, Raymond JR, Garnovskaya MN, Liddle RA. Inhibition of Na+/H+ exchange stimulates CCK secretion in STC-1 cells. Am J Physiol. 1998 10; 275(4):G689-95.
-
Brawman-Mintzer O, Lydiard RB, Bradwejn J, Villarreal G, Knapp R, Emmanuel N, Ware MR, He Q, Ballenger JC. Effects of the cholecystokinin agonist pentagastrin in patients with generalized anxiety disorder. Am J Psychiatry. 1997 May; 154(5):700-2.
-
Johnson MR, Lydiard RB, Ballenger JC. Panic disorder. Pathophysiology and drug treatment. Drugs. 1995 Mar; 49(3):328-44.
-
Hooks MS, Sorg BA, Kalivas PW. The relationship between MRNA levels and the locomotor response to novelty. Brain Res. 1994 Nov 14; 663(2):312-6.
-
Uhde TW. Anxiety and growth disturbance: is there a connection? A review of biological studies in social phobia. J Clin Psychiatry. 1994 Jun; 55 Suppl:17-27.
-
Lydiard RB, Ballenger JC, Laraia MT, Fossey MD, Beinfeld MC. CSF cholecystokinin concentrations in patients with panic disorder and in normal comparison subjects. Am J Psychiatry. 1992 May; 149(5):691-3.
-
Kost LJ, Gores GJ, Sayles JM, Miller LJ, Lemasters JJ, Herman B, LaRusso NF. Lack of metabolic effects of cholecystokinin on hepatocytes. Hepatology. 1990 Aug; 12(2):301-5.
-
Madison LD, Jamieson JD, Rosenzweig SA. Heterogeneity of cholecystokinin receptors in pancreas. Biochem Biophys Res Commun. 1987 Mar 13; 143(2):761-7.